|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | |
| A61K 31/4709 | |||
| A61P 35/00 |
| (11) | Number of the document | 3231797 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15867543.9 |
| Date of filing the European patent application | 2015-12-09 | |
| (97) | Date of publication of the European application | 2017-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2015/096777 |
| Date | 2015-12-09 |
| (87) | Number | WO 2016/091168 |
| Date | 2016-06-16 |
| (30) | Number | Date | Country code |
| 201410749394 | 2014-12-09 | CN |
| (72) |
WANG, Xunqiang, CN
MIAO, Yadong, CN
ZHOU, Min, CN
WANG, Shanchun, CN
YANG, Ling, CN
SHI, Wei, CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,
No. 369 Yuzhou South Road Haizhou District Lianyungang, Jiangsu 222062,
CN
Advenchen Laboratories Nanjing Ltd., Room 302, Block A, Pharmaceutical & Biology Incubator Building Entrepreneurship Center Nanjing New & High Tech Zone, Nanjing, Jiangsu 210061, CN |
| (54) | QUINOLINE DERIVATIVE AGAINST NON-SMALL CELL LUNG CANCER |
| QUINOLINE DERIVATIVE AGAINST NON-SMALL CELL LUNG CANCER |